What is the 13F Pro Quality Score for TNON?

13F Pro ranks Tenon Medical, Inc. (TNON) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View TNON's current score at https://13fpro.ai/research/TNON (free sign-up required for the full ranking).

Where does 13F Pro source TNON data?

All Tenon Medical, Inc. fundamentals and ownership data come directly from SEC EDGAR. Tenon Medical, Inc. files with the SEC under CIK 1560293. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is TNON in?

Tenon Medical, Inc. (TNON) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is TNON research updated on 13F Pro?

TNON's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

Tenon Medical, Inc.(TNON)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →Nasdaq

Institutional-grade research for retail investors

SEC EDGAR: CIK 1560293 TNON stock profile & AI dashboard →

13F Pro Quality Score

Not in ranked universe

Below size threshold

Quality rankings require at least $50M annual revenue or $250M total assets to filter out micro-caps and shell companies. This company reported $3.9M in revenue.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

TNON Stock Analysis & AI Quality Score

AI stock analysis and institutional research for Tenon Medical, Inc. (TNON), a Healthcare sector company. TNON is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least $50m annual revenue or $250m total assets to filter out micro-caps and shell companies. this company reported $3.9m in revenue. Based on the latest XBRL financial filings (Q1 2026), Tenon Medical, Inc. reports quarterly revenue of $1.4M, net income of $-3.5M, free cash flow of $-3.0M. Top institutional holders of TNON by reported 13-F value include GEODE CAPITAL MANAGEMENT,, VANGUARD CAPITAL MANAGEMENT, Focus Partners Wealth, based on the most recent SEC filings. TNON trades on the Nasdaq exchange and files with the SEC under CIK 1560293. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate TNON daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Tenon Medical, Inc. directly from SEC EDGAR.

Revenue

Q1 2026

$1.4M

Net Income

Q1 2026

$-3.5M

Free Cash Flow

Q1 2026

$-3.0M

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

+20.4% YoY

$3.9MFY 2025

FY22 $691.0KFY23 $2.3MFY24 $3.3MFY25 $3.9M

Net Income

+8.2% YoY

$-12.6MFY 2025

FY22 $-18.9MFY23 $-15.6MFY24 $-13.7MFY25 $-12.6M

Operating Income

+7.1% YoY

$-12.8MFY 2025

FY22 $-18.7MFY23 $-15.7MFY24 $-13.8MFY25 $-12.8M

EPS (Diluted)

+84.9% YoY

$-1.70FY 2025

FY22 $-23.62FY23 $-68.64FY24 $-11.26FY25 $-1.70

Total Assets

+9.3% YoY

$10.8MFY 2025

FY22 $11.1MFY23 $6.3MFY24 $9.8MFY25 $10.8M

Op. Cash Flow

-8.8% YoY

$-10.7MFY 2025

FY22 $-12.0MFY23 $-12.2MFY24 $-9.9MFY25 $-10.7M

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Revenue	$3.9M +20.4%	$3.3M +45.6%	$2.3M +225.6%	$691.0K +331.9%	$160.0K
Net Income	$-12.6M +8.2%	$-13.7M +12.2%	$-15.6M +17.6%	$-18.9M -168.4%	$-7.0M
Operating Income	$-12.8M +7.1%	$-13.8M +12.5%	$-15.7M +16.0%	$-18.7M -189.8%	$-6.5M
EPS (Diluted)	$-1.70 +84.9%	$-11.26 +83.6%	$-68.64 -190.6%	$-23.62 -202.4%	$-7.81
Total Assets	$10.8M +9.3%	$9.8M +55.1%	$6.3M -42.8%	$11.1M +19.6%	$9.3M
Operating Cash Flow	$-10.7M -8.8%	$-9.9M +18.9%	$-12.2M -1.3%	$-12.0M -180.2%	$-4.3M

AI Insight: TNON Financial Trends

Tenon Medical remains pre-revenue with persistent $3M quarterly operating losses and equity eroded 80% to $2M since Q2 2024.

• Revenue flat at $1M across all 8 quarters; operating income consistently negative at $3–4M per quarter.

• Operating cash flow negative throughout period, ranging $2–4M per quarter with no improvement trend.

• Equity deteriorated from $1M (Q2 2024) to $2M (Q1 2026), reflecting cumulative losses without debt financing.

⚠ Equity runway critically low at $2M; continued $3M quarterly cash burn leaves <1 quarter of liquidity.

⚠ No revenue acceleration or cost containment evident over 8-quarter span; operational model remains unproven.

AI Insight: TNON Ratio Trends

Tenon Medical is deeply unprofitable with operating margin at -193.5% in Q4 2025, signaling severe operational distress.

• Operating margin collapsed to -193.5% and net profit margin to -191.2% in Q4 2025, indicating massive losses relative to revenue.

• ROE deteriorated from -154.3% in Q1 2025 to -165.0% in Q2 2025, reflecting consistent shareholder value destruction.

• ROA worsened from -97.7% in Q3 2024 to -99.7% in Q2 2025, showing near-total asset inefficiency.

⚠ Most profitability metrics are missing for recent quarters; earnings visibility is severely limited and raises data completeness concerns.

⚠ No leverage or debt ratios reported; balance sheet structure and financial flexibility cannot be assessed from available data.

Get alerted when TNON's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Tenon Medical, Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of TNON

GEODE CAPITAL MANAGEMENT, LLC
$121.5K167,486 sh
VANGUARD CAPITAL MANAGEMENT LLC
$52.1K71,715 sh
Focus Partners Wealth
$39.6K61,887 sh
VANGUARD FIDUCIARY TRUST CO
$32.4K44,628 sh
SBI Securities Co., Ltd.
$28.8K39,722 sh
NORTHERN TRUST CORP
$13.1K18,048 sh
Spectrum Asset Management, Inc. (NB/CA)
$7.7K10,650 sh
Clear Street Group Inc.
$7.6K952,894 sh
CITIGROUP INC
$7.2K9,857 sh
Spectrum Asset Management, Inc. (NB/CA)
$5.4K679,420 sh

Fund	Value	Shares
GEODE CAPITAL MANAGEMENT, LLC	$121.5K	167,486
VANGUARD CAPITAL MANAGEMENT LLC	$52.1K	71,715
Focus Partners Wealth	$39.6K	61,887
VANGUARD FIDUCIARY TRUST CO	$32.4K	44,628
SBI Securities Co., Ltd.	$28.8K	39,722
NORTHERN TRUST CORP	$13.1K	18,048
Spectrum Asset Management, Inc. (NB/CA)	$7.7K	10,650
Clear Street Group Inc.	$7.6K	952,894
CITIGROUP INC	$7.2K	9,857
Spectrum Asset Management, Inc. (NB/CA)	$5.4K	679,420

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put TNON on your watchlist

Track score changes the day Tenon Medical, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is TNON a good stock to buy?

13F Pro's AI-powered analysis of Tenon Medical, Inc. (TNON) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for TNON are available on the TNON stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own TNON?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling TNON. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Tenon Medical, Inc.'s investment landscape.